Fulgent Genetics, Inc. (FLGT) Total Assets by Year
Fulgent Genetics, Inc. closed fiscal year 2025 with $1.2B in total assets, $106.8M in total liabilities and $1.1B in shareholder equity. This represents a decrease of 0.5% from the prior fiscal year. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters Fulgent Genetics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
FLGT Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.2B-0.5% | $1.2B-1.2% | $1.2B-10.9% | $1.4B+8.4% | $1.3B+82.6% | $700.5M+689.2% | $88.8M+64.7% | $53.9M-5.7% | $57.2M-1.5% | $58.0M+895.2% | $5.8M | N/A |
| Total Liabilities | $106.8M+17.6% | $90.8M-11.0% | $102.0M-12.2% | $116.2M+3.0% | $112.8M-13.9% | $131.1M+2092.2% | $6.0M+117.3% | $2.8M-8.4% | $3.0M-15.6% | $3.6M+419.1% | $686K | N/A |
| Total Equity | $1.1B-1.9% | $1.1B-0.3% | $1.1B-10.3% | $1.3B+9.3% | $1.2B+103.5% | $569.4M+587.9% | $82.8M+61.8% | $51.2M-5.6% | $54.2M-0.6% | $54.5M+958.7% | $5.1M+205.6% | $1.7M |
FLGT Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.1B-9.2% | $1.2B-4.1% | $1.2B-0.5% | $1.2B-1.6% | $1.2B-2.6% | $1.2B-2.0% | $1.2B-1.2% | $1.2B-9.2% | $1.2B-9.0% | $1.2B-10.7% | $1.2B-10.9% | $1.4B-3.4% |
| Total Liabilities | $93.2M+5.7% | $112.2M+35.2% | $106.8M+17.6% | $93.8M-5.1% | $88.2M-14.7% | $83.0M-19.6% | $90.8M-11.0% | $98.9M+2.4% | $103.4M+13.3% | $103.2M-4.3% | $102.0M-12.2% | $96.6M-22.4% |
| Total Equity | $1.0B-10.3% | $1.0B-6.9% | $1.1B-1.9% | $1.1B-1.1% | $1.1B-1.4% | $1.1B-0.2% | $1.1B-0.3% | $1.1B-9.6% | $1.1B-10.1% | $1.1B-10.6% | $1.1B-10.3% | $1.3B-1.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Fulgent Genetics, Inc. financials
Frequently Asked Questions
What was Fulgent Genetics, Inc.'s total assets in fiscal year 2025?
Fulgent Genetics, Inc. closed fiscal year 2025 with $1.2B in total assets, $106.8M in total liabilities and $1.1B in shareholder equity.
How fast is Fulgent Genetics, Inc.'s total assets growing?
Fulgent Genetics, Inc. (FLGT) total assets fell by 0.5% year over year, from $1.2B to $1.2B in fiscal year 2025.
What was Fulgent Genetics, Inc.'s total assets in the most recent quarter?
Fulgent Genetics, Inc. (FLGT) reported $1.1B in total assets in Q2 2026. This represents a decrease of 9.2% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Fulgent Genetics, Inc. (FLGT) reported on that line in every period on record.